![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07C 227/10 | |
C07C 227/18 | |||
C07C 229/30 | |||
C07D 405/04 |
(11) | Number of the document | 3089961 |
(13) | Kind of document | T |
(96) | European patent application number | 14828037.3 |
Date of filing the European patent application | 2014-12-23 | |
(97) | Date of publication of the European application | 2016-11-09 |
(45) | Date of publication and mention of the grant of the patent | 2018-07-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/079150 |
Date | 2014-12-23 |
(87) | Number | WO 2015/101554 |
Date | 2015-07-09 |
(30) | Number | Date | Country code |
PCT/CN2013/0910 | 2013-12-31 | WO |
(72) |
ZHENG, Juncheng, CN
DENG, Da, CN
LV, Guanghua, CN
YAN, Jun, CN
BRANDENBURG, Joerg, DE
KROEBER, Jutta, DE
SCHOLZ, Ulrich, DE
|
(73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
(54) | PROCESS FOR THE MANUFACTURE OF (E)-4-N,N-DIALKYLAMINO CROTONIC ACID IN HX SALT FORM AND USE THEREOF FOR SYNTHESIS OF EGFR TYROSINE KINASE INHIBITORS |
PROCESS FOR THE MANUFACTURE OF (E)-4-N,N-DIALKYLAMINO CROTONIC ACID IN HX SALT FORM AND USE THEREOF FOR SYNTHESIS OF EGFR TYROSINE KINASE INHIBITORS |